Skip to Content

Showing 1-1 of 1

Sorted By:

  • MEPO Study

    Mepolizumab Long-term Access Program for Subjects who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Standard-of-care Therapy)

Showing trial 1 of 1